Abstract
Psoriasis is a common T cell-mediated autoimmune disorder where primary onset of skin lesions is followed by chronic relapses. Progress in defining the mechanism for initiation of pathological events has been hampered by the lack of a relevant experimental model in which psoriasis develops spontaneously. We present a new animal model in which skin lesions spontaneously developed when symptomless prepsoriatic human skin was engrafted onto AGR129 mice, deficient in type I and type II interferon receptors and for the recombination activating gene 2. Upon engraftment, resident human T cells in prepsoriatic skin underwent local proliferation. T cell proliferation was crucial for development of a psoriatic phenotype because blocking of T cells led to inhibition of psoriasis development. Tumor necrosis factor-alpha was a key regulator of local T cell proliferation and subsequent disease development. Our observations highlight the importance of resident T cells in the context of lesional tumor necrosis factor-alpha production during development of a psoriatic lesion. These findings underline the importance of resident immune cells in psoriasis and will have implications for new therapeutic strategies for psoriasis and other T cell-mediated diseases.
MeSH Terms
Animals
Cell Division
DNA-Binding Proteins/deficiency,genetics,immunology
Disease Models, Animal
Humans
Membrane Proteins
Mice
Mice, Inbred C57BL
Mice, Knockout
Nuclear Proteins
Phenotype
Psoriasis/etiology,immunology,pathology
Receptor, Interferon alpha-beta
Receptors, Interferon/deficiency,genetics
Skin Transplantation
T-Lymphocytes/immunology,pathology
Transplantation, Heterologous
Tumor Necrosis Factor-alpha/biosynthesis
Chemicals
DNA-Binding Proteins
Membrane Proteins
Nuclear Proteins
RAG2 protein, human
Rag2 protein, mouse
Receptors, Interferon
Tumor Necrosis Factor-alpha
V(D)J recombination activating protein 2
interferon receptor, type II
Receptor, Interferon alpha-beta
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Boyman Onur
Department of Dermatology, University Hospital of Zurich, Gloriastrasse 31, CH-8091, Switzerland.
Hefti Hans Peter
Conrad Curdin
Nickoloff Brian J
Suter Mark
Nestle Frank O
References (25)
25 references, click to expand
-
Distinct requirements for IFNs and STAT1 in NK cell function.
J Immunol. 2000 Oct 1;165(7):3571-7
PMID: 11034357
-
Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial.
Lancet. 2000 Jul 29;356(9227):385-90
PMID: 10972371
-
Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial.
Lancet. 2001 Jun 9;357(9271):1842-7
PMID: 11410193
-
Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes.
N Engl J Med. 2001 Jul 26;345(4):248-55
PMID: 11474662
-
Migration of T cells in vivo: molecular mechanisms and clinical implications.
Ann Intern Med. 2001 Aug 21;135(4):279-95
PMID: 11511143
-
The immunologic basis for the treatment of psoriasis with new biologic agents.
J Am Acad Dermatol. 2002 Jan;46(1):1-23; quiz 23-6
PMID: 11756941
-
Transplantation of psoriatic skin onto nude mice.
J Invest Dermatol. 1983 Jun;80 Suppl:31s-35s
PMID: 6343518
-
T-cell subpopulations in the blood and skin of patients with psoriasis.
Br J Dermatol. 1984 Jan;110(1):37-44
PMID: 6229268
-
Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis.
Am J Pathol. 1991 Jan;138(1):129-40
PMID: 1702929
-
The pathophysiology of psoriasis.
Lancet. 1991 Jul 27;338(8761):227-30
PMID: 1676787
-
The pathophysiology of tumor necrosis factors.
Annu Rev Immunol. 1992;10:411-52
PMID: 1590993
-
Functional role of type I and type II interferons in antiviral defense.
Science. 1994 Jun 24;264(5167):1918-21
PMID: 8009221
-
Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis.
Nat Med. 1995 May;1(5):442-7
PMID: 7585092
-
Pulling the trigger on psoriasis.
Nature. 1996 Feb 29;379(6568):777
PMID: 8587600
-
The immunopathology of psoriasis.
Int Arch Allergy Immunol. 1996 Jul;110(3):199-206
PMID: 8688665
-
Psoriasis, T cells and autoimmunity.
J R Soc Med. 1996 Jun;89(6):315-9
PMID: 8758188
-
Dermal injection of immunocytes induces psoriasis.
J Clin Invest. 1996 Oct 15;98(8):1878-87
PMID: 8878440
-
Murine psoriasis-like disorder induced by naive CD4+ T cells.
Nat Med. 1997 Feb;3(2):183-8
PMID: 9018237
-
Pathogenesis and immunotherapy of autoimmune diseases.
Immunol Today. 1997 May;18(5):209-11
PMID: 9153950
-
Importance of natural killer cells in the rejection of hamster skin xenografts.
Transplantation. 1998 Mar 15;65(5):727-34
PMID: 9521210
-
Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo.
Nat Med. 1999 Apr;5(4):405-11
PMID: 10202929
-
Role of the individual interferon systems and specific immunity in mice in controlling systemic dissemination of attenuated pseudorabies virus infection.
J Virol. 1999 Jun;73(6):4748-54
PMID: 10233935
-
Natural killer cells in antiviral defense: function and regulation by innate cytokines.
Annu Rev Immunol. 1999;17:189-220
PMID: 10358757
-
Interferon gamma contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy.
J Exp Med. 2000 Jul 17;192(2):259-70
PMID: 10899912
-
Homeostatic T cell proliferation: how far can T cells be activated to self-ligands?
J Exp Med. 2000 Aug 21;192(4):F9-F14
PMID: 10952731